Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.780
+0.025 (1.42%)
At close: May 17, 2024, 4:00 PM
1.710
-0.070 (-3.93%)
After-hours: May 17, 2024, 4:51 PM EDT

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $97.26 million. The enterprise value is $80.90 million.

Market Cap 97.26M
Enterprise Value 80.90M

Important Dates

The last earnings date was Tuesday, April 16, 2024, after market close.

Earnings Date Apr 16, 2024
Ex-Dividend Date n/a

Share Statistics

CNTB has 55.10 million shares outstanding.

Shares Outstanding 55.10M
Owned by Insiders (%) 41.27%
Owned by Institutions (%) 43.81%
Float 16.05M

Valuation Ratios

PE Ratio n/a
Forward PE 1.87
PS Ratio n/a
Forward PS n/a
PB Ratio 6.95
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.99, with a Debt / Equity ratio of 0.00.

Current Ratio 4.99
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,580.87

Financial Efficiency

Return on equity (ROE) is -46.00% and return on invested capital (ROIC) is -61.15%.

Return on Equity (ROE) -46.00%
Return on Assets (ROA) -39.70%
Return on Capital (ROIC) -61.15%
Revenue Per Employee n/a
Profits Per Employee -$734,605
Employee Count 81
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CNTB has paid $16,612 in taxes.

Income Tax 16,612
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +52.66% in the last 52 weeks. The beta is -0.49, so CNTB's price volatility has been lower than the market average.

Beta (1Y) -0.49
52-Week Price Change +52.66%
50-Day Moving Average 1.55
200-Day Moving Average 1.20
Relative Strength Index (RSI) 57.62
Average Volume (30 Days) 168,251

Short Selling Information

Short Interest 31,231
Short Previous Month 83,144
Short % of Shares Out 0.10%
Short % of Float n/a
Short Ratio (days to cover) 0.18

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.59M
Pretax Income -8.22M
Net Income -59.50M
EBITDA -8.22M
EBIT -8.22M
Earnings Per Share (EPS) -$0.15
Full Income Statement

Balance Sheet

The company has $16.43 million in cash and $64,372 in debt, giving a net cash position of $16.36 million or $0.30 per share.

Cash & Cash Equivalents 16.43M
Total Debt 64,372
Net Cash 16.36M
Net Cash Per Share $0.30
Equity / Book Value 13.99M
Book Value Per Share 0.25
Working Capital 13.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.64 million and capital expenditures $366,715, giving a free cash flow of -$6.27 million.

Operating Cash Flow -6.64M
Capital Expenditures 366,715
Free Cash Flow -6.27M
FCF Per Share -$0.11
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.25%
Shareholder Yield 4.25%
Earnings Yield -61.18%
FCF Yield -6.45%

Analyst Forecast

The average price target for CNTB is $6.50, which is 265.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.50
Price Target Difference 265.17%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3